Search results
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 11 hours agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
Does AI Really Make Moderna Stock (NASDAQ:MRNA) a Buy?
TipRanks via Yahoo Finance· 6 days agoModerna (NASDAQ:MRNA) stock has collapsed from its all-time high. However, the company is once again...
Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting
The Joplin Globe· 2 days agoModerna to host an investor event via webcast on Monday, June 3 at 6:15 PM CDT
Biotech stocks are rising alongside bird flu fears
Semafor via Yahoo Finance· 7 hours agoVaccine makers, including Moderna, BioNTech, and CureVac, all saw double-digit stock increases, as investors bet they could cash in on a public health...
Moderna wins case in patent dispute with Pfizer, BioNTech over COVID shot
WHTC 1450 Holland· 6 days ago(Reuters) -Moderna has won a case at the European Patent Office in its dispute with Pfizer and...
Oracle, Moderna, Palantir Technologies And A Big Bank On CNBC’s ‘Final Trades’ - Oracle (NYSE:ORCL)
Benzinga· 2 days agoOn CNBC's "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Oracle Corporation...
Moderna wins a battle in vaccine patent dispute with Pfizer-BioNTech - The Boston Globe
The Boston Globe· 6 days agoModerna said Friday that the European Patent Office has upheld the validity of one of its key...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga· 6 days agoModerna Inc MRNA has reportedly achieved a significant victory at the European Patent Office (EPO)...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 3 days agoVaccine makers Moderna and Novavax are hoping for an August rollout this year, earlier than last...
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga via Yahoo Finance· 6 days agoModerna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent...